Ryan S. Noble's most recent trade in Kewaunee Scientific Corporation was a trade of 7,206 Common Stock done . Disclosure was reported to the exchange on June 30, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kewaunee Scientific Corp | Ryan S. Noble | SVP, Sales & Marketing Dev | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 7,206 | 21,049 (0%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corp | Ryan S. Noble | SVP, Sales & Marketing Dev | Sale or transfer of securities back to the company at price $ 36.25 per share. | 30 Jun 2026 | 3,000 | 18,049 (0%) | 0% | 36.3 | 108,750 | Common Stock |
| Kewaunee Scientific Corp | Ryan S. Noble | SVP, Sales & Marketing Dev | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 2,942 | 0 | - | - | Restricted Stock Units FY24 | |
| Kewaunee Scientific Corp | Ryan S. Noble | SVP, Sales & Marketing Dev | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.25 per share. | 30 Jun 2026 | 1,809 | 16,240 (0%) | 0% | 36.2 | 65,576 | Common Stock |
| Kewaunee Scientific Corp | Ryan S. Noble | SVP, Sales & Marketing Dev | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 730 | 3,650 | - | - | Restricted Stock Units FY26 | |
| Kewaunee Scientific Corp | Ryan S. Noble | SVP, Sales & Marketing Dev | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2026 | 534 | 2,939 | - | - | Restricted Stock Units FY25 | |
| Kewaunee Scientific Corp | Ryan S. Noble | SVP, Sales & Marketing Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2026 | 2,628 | 2,628 | - | - | Restricted Stock Units FY27 | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 2,959 | 14,782 (0%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 1,908 | 0 | - | - | Restricted Stock Units FY23 | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.34 per share. | 30 Jun 2025 | 939 | 13,843 (0%) | 0% | 58.3 | 54,781 | Common Stock |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 534 | 3,473 | - | - | Restricted Stock Units FY25 | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2025 | 517 | 4,133 | - | - | Restricted Stock Units FY24 | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2025 | 4,380 | 4,380 | - | - | Restricted Stock Units FY26 | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Sale of securities on an exchange or to another person at price $ 66.00 per share. | 30 Dec 2024 | 1,500 | 11,823 (0%) | 0% | 66 | 99,000 | Common Stock |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 4,057 | 15,042 (0%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 1,907 | 1,908 | - | - | Restricted Stock Units FY23 | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.86 per share. | 30 Jun 2024 | 1,719 | 13,323 (0%) | 0% | 44.9 | 77,114 | Common Stock |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 1,633 | 0 | - | - | Restricted Stock Units FY22 | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 517 | 4,650 | - | - | Restricted Stock Units FY24 | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 4,007 | 4,007 | - | - | Restricted Stock Units FY25 | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Sale of securities on an exchange or to another person at price $ 33.26 per share. | 26 Mar 2024 | 692 | 10,985 (0%) | 0% | 33.3 | 23,016 | Common Stock |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Sale of securities on an exchange or to another person at price $ 33.00 per share. | 26 Mar 2024 | 58 | 11,677 (0%) | 0% | 33 | 1,914 | Common Stock |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Sale of securities on an exchange or to another person at price $ 26.01 per share. | 19 Dec 2023 | 1,250 | 11,735 (0%) | 0% | 26.0 | 32,513 | Common Stock |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 3,541 | 13,988 (0%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 1,907 | 3,815 | - | - | Restricted Stock Units FY23 | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 1,634 | 1,633 | - | - | Restricted Stock Units FY22 | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.90 per share. | 30 Jun 2023 | 1,003 | 12,985 (0%) | 0% | 15.9 | 15,948 | Common Stock |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 5,167 | 5,167 | - | - | Restricted Stock Units FY24 | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2023 | 6,326 | 12,238 (0%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2023 | 5,252 | 0 | - | - | Restricted Stock Units FY21 | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.47 per share. | 23 Jun 2023 | 1,791 | 10,447 (0%) | 0% | 16.5 | 29,498 | Common Stock |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 5,722 | 5,722 | - | - | Restricted Stock Units FY23 | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2022 | 1,634 | 3,267 | - | - | Restricted Stock Units FY22 | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2022 | 1,634 | 6,379 (0%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.77 per share. | 29 Jun 2022 | 467 | 5,912 (0%) | 0% | 15.8 | 7,365 | Common Stock |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2022 | 955 | 5,252 | - | - | Restricted Stock Units FY21 | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2022 | 955 | 5,018 (0%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.82 per share. | 23 Jun 2022 | 273 | 4,745 (0%) | 0% | 13.8 | 3,773 | Common Stock |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2022 | 2,243 | 0 | - | - | Restricted Stock Units | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2022 | 2,243 | 4,704 (0%) | 0% | 0 | Common Stock | |
| Kewaunee Scientific Corp | Ryan S. Noble | VP-Sales & Marketing-Americas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.99 per share. | 21 Jun 2022 | 641 | 4,063 (0%) | 0% | 14.0 | 8,968 | Common Stock |